1-3 of 3
Michael D Craig, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Improved Survival in Patients with First Relapsed or Refractory Acute Myeloid Leukemia (AML) Treated with Vosaroxin Plus Cytarabine Versus Placebo Plus Cytarabine: Results of a Phase 3 Double-Blind Randomized Controlled Multinational Study (VALOR)

Farhad Ravandi, MD, Ellen Ritchie, MD, Hamid Sayar, MD, Jeffrey Lancet, MD, Michael D. Craig, MD, Norbert Vey, MD, Stephen A. Strickland, MD, Gary Schiller, MD, Elias Jabbour, MD, Harry P. Erba, MD PhD, Arnaud Pigneux, MD, Heinz-August Horst, MD, Christian Recher, MD, Virginia M. Klimek, MD, Jorge Cortes, MD, Eric J. Feldman, MD, Adam R. Craig, MD PhD, Judith A. Fox, PhD, Renee Ward, MD PhD, Jennifer Smith, PhD, Gary Acton, MD, Cyrus Mehta, PhD, Hagop M. Kantarjian, MD, Robert K Stuart, MD
Journal: Blood
Blood (2014) 124 (21): LBA-6.
https://doi.org/10.1182/blood.V124.21.LBA-6.LBA-6
Published: 2014
Journal Articles

Phase 2 Study of MLN8237, An Investigational Aurora A Kinase (AAK) Inhibitor In Patients with Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndromes (MDS)

Stuart L Goldberg, MD, Pierre Fenaux, MD, PhD, Michael D Craig, MD, Emmanuel Gyan, MD, PhD, John Lister, MD, Jeannine Kassis, MD, Arnaud Pigneux, MD, PhD, Gary J Schiller, MD, JungAh Jung, PhD, E. Jane Leonard, MSc, Howard Fingert, MD, Peter Westervelt, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3273.
https://doi.org/10.1182/blood.V116.21.3273.3273
Published: 2010
Journal Articles

Effect of T-Cell Dose On Outcomes After Peripheral Blood Allogeneic Hematopoietic Cell Transplantation in Hematological Malignancies.

Abraham S Kanate, MD, Farhad Khimani, MD, Aaron Cumpston, PharmD, Kathy Watkins, BS, Sonia Leadmon, BS, Michael D Craig, MD
Journal: Blood
Blood (2009) 114 (22): 1171.
https://doi.org/10.1182/blood.V114.22.1171.1171
Published: 2009